ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
6 announcements
Panacea Biotec received four income tax demand orders totaling ₹9.82 Crore for alleged misreporting. The company contests this as non-maintainable and plans to appeal.
Panacea Biotec sent reminder letters to physical shareholders requesting PAN and KYC updates per SEBI circulars. No transaction or business event is involved.
Panacea Biotec Limited issued the notice for its 42nd Annual General Meeting scheduled for September 29, 2026, via video conferencing. Shareholders can participate through remote e-voting.
Panacea Biotec Limited has submitted its monthly share dematerialization report for August 2026. This is a routine regulatory compliance filing under SEBI Regulation 74(5).
Panacea Biotec Ltd reported revenue from operations of ₹199.6 Cr (+19.7% YoY) and net profit of ₹2.2 Cr (-45.0% YoY) for Q1 FY27.
Panacea Biotec Ltd reported revenue from operations of ₹166.8 Cr (+25.9% YoY) and a net loss of ₹1 Cr for Q4 FY26.